Joseph T. August serves as Executive at UNIGENE LABORATORIES INC, where they oversee executive responsibilities. Since joining the company, Joseph T. August has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 1, 2010 involved receiving (via award) 10,000 shares valued at $0.
Joseph T. August currently holds 217,025 shares of UNIGENE LABORATORIES INC (UGNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph T. August has been a net neutral trader of UGNE stock. They have purchased $0 and sold $0 worth of shares.
Joseph T. August's most recent insider trade was on May 1, 2010, when they sold 10,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.72 |
| Discretionary |
| Aug 19, 2009 | UGNE | $56.4K | Option Exercise | 120,000 | $0.47 | Discretionary |
| Aug 19, 2009 | UGNE | $8.8K | Option Exercise | 21,000 | $0.42 | Discretionary |
| Aug 19, 2009 | UGNE | $6.6K | Option Exercise | 10,000 | $0.66 | Discretionary |
| Aug 19, 2009 | UGNE | $3.4K | Option Exercise | 10,000 | $0.34 | Discretionary |
| Jul 6, 2009 | UGNE | $4.5K | Award | 3,214 | $1.40 | Discretionary |
| May 1, 2009 | UGNE | $0 | Award | 10,000 | $N/A | Discretionary |
| Jan 6, 2009 | UGNE | $4.5K | Award | 7,759 | $0.58 | Discretionary |